380 related articles for article (PubMed ID: 25460020)
1. Rodent models of treatment-resistant depression.
Caldarone BJ; Zachariou V; King SL
Eur J Pharmacol; 2015 Apr; 753():51-65. PubMed ID: 25460020
[TBL] [Abstract][Full Text] [Related]
2. Faster, better, stronger: towards new antidepressant therapeutic strategies.
O'Leary OF; Dinan TG; Cryan JF
Eur J Pharmacol; 2015 Apr; 753():32-50. PubMed ID: 25092200
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the adrenocorticotrophic hormone - induced mouse model of resistance to antidepressant drug treatment.
Srikumar BN; Paschapur M; Kalidindi N; Adepu B; Das ML; Sreedhara MV; Kuchibhotla VK; Pieschl RL; Li YW; Ega DSP; Louis JV; Murugesan S; Naidu PS; Ramarao M; Bristow LJ; Vikramadithyan RK
Pharmacol Biochem Behav; 2017 Oct; 161():53-61. PubMed ID: 28911960
[TBL] [Abstract][Full Text] [Related]
4. Lithium augmentation of the effects of desipramine in a mouse model of treatment-resistant depression: a role for hippocampal cell proliferation.
O'Leary OF; Zandy S; Dinan TG; Cryan JF
Neuroscience; 2013 Jan; 228():36-46. PubMed ID: 23069753
[TBL] [Abstract][Full Text] [Related]
5. Treatment-resistant depression: are animal models of depression fit for purpose?
Willner P; Belzung C
Psychopharmacology (Berl); 2015 Oct; 232(19):3473-95. PubMed ID: 26289353
[TBL] [Abstract][Full Text] [Related]
6. Using adjunctive treatments when first-line antidepressants fail.
Thase ME
J Clin Psychiatry; 2012 Jan; 73(1):e01. PubMed ID: 22316580
[TBL] [Abstract][Full Text] [Related]
7. Gene expression signature of antidepressant treatment response/non-response in Flinders Sensitive Line rats subjected to maternal separation.
Marchetti L; Lauria M; Caberlotto L; Musazzi L; Popoli M; Mathé AA; Domenici E; Carboni L
Eur Neuropsychopharmacol; 2020 Feb; 31():69-85. PubMed ID: 31813757
[TBL] [Abstract][Full Text] [Related]
8. [Sequential prescriptions: Arguments for a change of therapeutic patterns in treatment resistant depressions].
Allouche G
Encephale; 2016 Feb; 42(1):32-8. PubMed ID: 26358484
[TBL] [Abstract][Full Text] [Related]
9. European Group for the Study of Resistant Depression (GSRD)--where have we gone so far: review of clinical and genetic findings.
Schosser A; Serretti A; Souery D; Mendlewicz J; Zohar J; Montgomery S; Kasper S
Eur Neuropsychopharmacol; 2012 Jul; 22(7):453-68. PubMed ID: 22464339
[TBL] [Abstract][Full Text] [Related]
10. Towards translational rodent models of depression.
O'Leary OF; Cryan JF
Cell Tissue Res; 2013 Oct; 354(1):141-53. PubMed ID: 23525777
[TBL] [Abstract][Full Text] [Related]
11. Investigating Resistance to Antidepressants in Animal Models.
Peña JE; Corbett BF; Tamminga CA; Bhatnagar S; Hitti FL
Neuroscience; 2024 Jun; 548():69-80. PubMed ID: 38697464
[TBL] [Abstract][Full Text] [Related]
12. Opportunities to discover genes regulating depression and antidepressant response from rodent behavioral genetics.
Crowley JJ; Lucki I
Curr Pharm Des; 2005; 11(2):157-69. PubMed ID: 15638756
[TBL] [Abstract][Full Text] [Related]
13. The role of GSK-3 in treatment-resistant depression and links with the pharmacological effects of lithium and ketamine: A review of the literature.
Costemale-Lacoste JF; Guilloux JP; Gaillard R
Encephale; 2016 Apr; 42(2):156-64. PubMed ID: 26995153
[TBL] [Abstract][Full Text] [Related]
14. [Ketamine's antidepressant effect: focus on ketamine mechanisms of action].
De Maricourt P; Jay T; Goncalvès P; Lôo H; Gaillard R
Encephale; 2014 Feb; 40(1):48-55. PubMed ID: 24434007
[TBL] [Abstract][Full Text] [Related]
15. New dimensions in the use of rodent behavioral tests for novel drug discovery and development.
Hoffman KL
Expert Opin Drug Discov; 2016; 11(4):343-53. PubMed ID: 26894954
[TBL] [Abstract][Full Text] [Related]
16. The integrative management of treatment-resistant depression: a comprehensive review and perspectives.
Carvalho AF; Berk M; Hyphantis TN; McIntyre RS
Psychother Psychosom; 2014; 83(2):70-88. PubMed ID: 24458008
[TBL] [Abstract][Full Text] [Related]
17. International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets.
Caraci F; Calabrese F; Molteni R; Bartova L; Dold M; Leggio GM; Fabbri C; Mendlewicz J; Racagni G; Kasper S; Riva MA; Drago F
Pharmacol Rev; 2018 Jul; 70(3):475-504. PubMed ID: 29884653
[TBL] [Abstract][Full Text] [Related]
18. The promise of ketamine for treatment-resistant depression: current evidence and future directions.
DeWilde KE; Levitch CF; Murrough JW; Mathew SJ; Iosifescu DV
Ann N Y Acad Sci; 2015 May; 1345(1):47-58. PubMed ID: 25649308
[TBL] [Abstract][Full Text] [Related]
19. Treatment resistant depression: A multi-scale, systems biology approach.
Akil H; Gordon J; Hen R; Javitch J; Mayberg H; McEwen B; Meaney MJ; Nestler EJ
Neurosci Biobehav Rev; 2018 Jan; 84():272-288. PubMed ID: 28859997
[TBL] [Abstract][Full Text] [Related]
20. Novel approaches for the management of depressive disorders.
Kaster MP; Moretti M; Cunha MP; Rodrigues AL
Eur J Pharmacol; 2016 Jan; 771():236-40. PubMed ID: 26703867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
